Organon (OGN) EPS (Weighted Average and Diluted) (2020 - 2026)

Organon's EPS (Weighted Average and Diluted) history runs 7 years deep, the most recent figure standing at $0.55 for Q1 2026.

• In Q1 2026, EPS (Weighted Average and Diluted) rose 66.67% year-over-year to $0.55; the TTM figure through Mar 2026 stood at $0.94 (down 67.25% YoY), while the FY2025 annual figure was $0.72, down 78.38% from the prior year.
• EPS (Weighted Average and Diluted) was $0.55 for Q1 2026 at Organon, up from -$0.78 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $2.13 in Q4 2023 to a low of -$0.78 in Q4 2025.
• Historically, EPS (Weighted Average and Diluted) has averaged $0.72 across 5 years, with a median of $0.69 in 2023.
• The sharpest annual moves came in 2024 and 2025: EPS (Weighted Average and Diluted) jumped 500.0% in 2024, then tumbled 290.24% in 2025.
• A 5-year view of EPS (Weighted Average and Diluted) shows it stood at $0.42 in 2022, then surged by 407.14% to $2.13 in 2023, then tumbled by 80.75% to $0.41 in 2024, then sank by 290.24% to -$0.78 in 2025, then soared by 170.51% to $0.55 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.55 (Q1 2026), -$0.78 (Q4 2025), and $0.61 (Q3 2025), per Business Quant data.